GLP-1s supplant Covid antiviral growth: Wesfarmers

As pharmacies looked to replace revenue from Covid antivirals, a new contender moved behind counters, a major player says  Weight loss drugs have become a top earner for Priceline Pharmacy parent Wesfarmers Health, replacing the gains from Covid antivirals, the division’s managing director told investors. At a briefing on the back of Wesfarmers’ half-year results,